Fentanyl’s dangerous effects potentially reversible by new compound

December 24, 2022

Maven Clinic receives $125 million to fund technology and value-based treatment

October 12, 2024

Zealand Pharma Presents Clinical Results From the Phase 3 Trial of Dasiglucagon

September 23, 2022

Must Read

Novartis Reports Positive Phase 1/2 Results for Del-Brax in FSHD

June 18, 2026

Is Pharma Ready for the Age of Autonomous Work?

June 16, 2026

Following Navacaprant’s disappointing late-stage results, Neumora will fire thirty-five percent of its employees

June 16, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Novartis Reports Positive Phase 1/2 Results for Del-Brax in FSHD

Caribou Gets CAR-T Boost Ahead of Phase 3 Trial

Takeda’s Inhibitor Gets the Better of BMS’ Sotyktu in Phase 3 Psoriasis Battle

Sanofi Ends Phase 3 Trial of Riliprubart in CIDP After Interim Review

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Is Pharma Ready for the Age of Autonomous Work?

Top 10 Forces Reshaping the Future of Life Sciences Operations

Precision Medicine Moves From Vision to Reality

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

Tag: Novartis

Novartis Names Texas as Site For RadioPharma Production Facility

Editor Picks

Fentanyl’s dangerous effects potentially reversible by new compound

Maven Clinic receives $125 million to fund technology and value-based treatment

Zealand Pharma Presents Clinical Results From the Phase 3 Trial of Dasiglucagon

Must Read

Novartis Reports Positive Phase 1/2 Results for Del-Brax in FSHD

Is Pharma Ready for the Age of Autonomous Work?

Following Navacaprant’s disappointing late-stage results, Neumora will fire thirty-five percent of its employees

Hot Topics

About Us

Follow Us